/2563 13 May 2020 Re Explanation and analysis of the Management for the 1st quarter of 2020 ended 31 March 2020 To Director and Manager, Stock Exchange of Thailand The Company would like to submit
0.15 ‐ Return on equity (%) 1.10% 17.42 ‐ Please be informed accordingly. Yours faithfully, Ekachai Medical Care PCL. (Dr. Amnaj Eur‐Areemitr) Director Ms. Nichanun
Microsoft Word - MD&A SET Q2'2020 ENG.doc Page 1 of 2 August 10, 2020 Re: Management Discussion and Analysis for Quarter 2/2020 (June 30 ,2020) To: Director and Manager of the Stock Exchange of
(Translated) August 11, 2020 Ref FSS 120/2020 Subject: Clarification of Company’s Operating Result for the six-month period ended June 30, 2020 To The President and Director The Stock Exchange of
. Malee Leelasiriwong) Director 2
/2563 13 Aug 2020 Re Explanation and analysis of the Management for the 2nd quarter of 2020 ended 30 June 2020 To Director and Manager, Stock Exchange of Thailand The Company would like to submit herewith
Finance Director
sincerely, (Lissapat Kraikruan) Director Company Secretary Department Tel. 02-192-3737 Ext. 700 (Mrs. Puntipa) Attachment Map of the Meeting Venue at Eureka Design Public Company Limited (Head Office) If you
number 24421, Bangbon Sub-district, Bangbon District, Bangkok from Mr. Kongsak Hemmontharop who is Board of Director and major shareholder of the Company. 7. To consider and approve the appointment of
(Translated) May 12, 2020 Ref FSS 080/2020 Subject: Clarification of Company’s Operating Result for the three-month period ended March 31, 2020 To The President and Director The Stock Exchange of